SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-17-008123
Filing Date
2017-09-05
Accepted
2017-09-05 09:00:36
Documents
1
Period of Report
2017-09-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT oxis_8k.htm 8-K 32587
  Complete submission text file 0001654954-17-008123.txt   34257
Mailing Address 100 SOUTH ASHLEY DRIVE SUITE 600 TAMPA FL 33602
Business Address 100 SOUTH ASHLEY DRIVE SUITE 600 TAMPA FL 33602 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-08092 | Film No.: 171067497
SIC: 2834 Pharmaceutical Preparations